Naperville, IL -- (SBWIRE) -- 06/16/2014 -- Reportstack, provider of premium market research reports announces the addition of China Pharmaceuticals and Healthcare Report Q3 2014 market report to its offering
In line with our optimism towards the Chinese healthcare sector, many multinational
pharmaceutical firms continue to record healthy double-digit revenue growth in Q114, despite the economic
slowdown. Given the attractiveness of the Chinese pharmaceutical market (due to its ageing population,
increasingly personal wealth and government support for healthcare), we expect continued investments
from foreign investors into the pharmaceutical and healthcare sector.
Headline Expenditure Projections
? Pharmaceuticals: CNY532.4bn (US$86.6bn) in 2013 to CNY610.8bn (US$99.7bn) in 2014; +14.7% in
local currency and +15.1% in US dollar terms. Forecast remains unchanged from Q213.
? Healthcare: CNY3,230.8bn (US$525.5bn) in 2013 to CNY3,692.0bn (US$602.6bn) in 2014; +14.3% in
local currency terms and +14.7% in US dollar terms. Forecast upgraded due to receipt of new data
from the World Health Organization.
To view the table of contents for this market research report please visit